Novel Diagnostic and Therapeutic Options for

KMT2A MLL acute leukemia biomarker machine learning therapy

Journal

Frontiers in pharmacology
ISSN: 1663-9812
Titre abrégé: Front Pharmacol
Pays: Switzerland
ID NLM: 101548923

Informations de publication

Date de publication:
2022
Historique:
received: 29 07 2021
accepted: 04 05 2022
entrez: 23 6 2022
pubmed: 24 6 2022
medline: 24 6 2022
Statut: epublish

Résumé

The

Identifiants

pubmed: 35734412
doi: 10.3389/fphar.2022.749472
pii: 749472
pmc: PMC9208280
doi:

Types de publication

Journal Article

Langues

eng

Pagination

749472

Informations de copyright

Copyright © 2022 Lopes, Poubel, Teixeira, Caye-Eude, Cavé, Meyer, Marschalek, Boroni and Emerenciano.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. The handling Editor declared a past co-authorship/collaboration with one of the authors HC.

Références

Blood Adv. 2020 Mar 10;4(5):930-942
pubmed: 32150610
Blood. 1996 Feb 1;87(3):1123-33
pubmed: 8562938
Bioinformatics. 2014 Aug 1;30(15):2114-20
pubmed: 24695404
Front Pharmacol. 2021 Sep 14;12:741413
pubmed: 34594227
Eur J Cancer. 2010 Dec;46(18):3358-64
pubmed: 20727737
Leukemia. 2014 Mar;28(3):589-99
pubmed: 24240200
Br J Haematol. 1999 Dec;107(3):674-6
pubmed: 10583275
BMC Bioinformatics. 2011 Aug 04;12:323
pubmed: 21816040
Nucleic Acids Res. 2016 May 5;44(8):e71
pubmed: 26704973
Int J Mol Sci. 2021 Jul 19;22(14):
pubmed: 34299320
Blood Adv. 2020 Dec 8;4(23):6077-6085
pubmed: 33290546
Bioinformatics. 2005 Aug 15;21(16):3439-40
pubmed: 16082012
N Engl J Med. 2015 May 14;372(20):1909-19
pubmed: 25970050
Leukemia. 2021 Jan;35(1):47-61
pubmed: 32127641
Blood. 1996 Feb 1;87(3):1134-9
pubmed: 8562939
Nature. 2019 May;569(7757):503-508
pubmed: 31068700
Cell Syst. 2019 Jul 24;9(1):24-34.e10
pubmed: 31344359
Cell Rep. 2018 Apr 3;23(1):227-238.e3
pubmed: 29617662
Cell Cycle. 2011 Dec 1;10(23):4138-48
pubmed: 22101270
Leukemia. 2000 Jul;14(7):1232-8
pubmed: 10914547
Clin Cancer Res. 2019 May 1;25(9):2795-2808
pubmed: 30651276
Nat Protoc. 2009;4(8):1184-91
pubmed: 19617889
Biochem Pharmacol. 2018 Jan;147:183-190
pubmed: 28943239
Nucleic Acids Res. 2021 Jan 8;49(D1):D1144-D1151
pubmed: 33237278
Nucleic Acids Res. 2012 May;40(10):4288-97
pubmed: 22287627
BMC Proc. 2014 Oct 13;8(Suppl 6 Proceedings of the Great Lakes Bioinformatics Confer):S2
pubmed: 25374611
Leuk Res. 2011 Aug;35(8):1001-7
pubmed: 21444110
Mol Cancer. 2019 Feb 19;18(1):26
pubmed: 30782187
Nucleic Acids Res. 2019 Jul 2;47(W1):W199-W205
pubmed: 31114916
Biochim Biophys Acta Gene Regul Mech. 2020 Sep;1863(9):194584
pubmed: 32534041
N Engl J Med. 2004 Apr 15;350(16):1617-28
pubmed: 15084694
Haematologica. 2022 Apr 01;107(4):803-815
pubmed: 33910331
Oncol Rep. 2019 Jan;41(1):125-132
pubmed: 30542720
Nucleic Acids Res. 2015 Apr 20;43(7):e47
pubmed: 25605792
Leukemia. 2005 Nov;19(11):1948-57
pubmed: 16107895
Biochim Biophys Acta Rev Cancer. 2017 Dec;1868(2):521-526
pubmed: 29056538
Nat Genet. 2017 Aug;49(8):1211-1218
pubmed: 28671688
Blood Adv. 2019 Oct 22;3(20):3157-3169
pubmed: 31648321
J Med Chem. 2014 Jan 23;57(2):449-61
pubmed: 24387105
Leuk Res. 2015 Feb;39(2):242-7
pubmed: 25510485
Blood Rev. 2021 Jan;45:100696
pubmed: 32482307
BMC Bioinformatics. 2011 Mar 17;12:77
pubmed: 21414208
Bioinformatics. 2010 Jan 1;26(1):139-40
pubmed: 19910308
Oncogene. 2021 Jun;40(25):4271-4280
pubmed: 34103684
Nature. 2018 Oct;562(7728):526-531
pubmed: 30333627
Leukemia. 2019 Sep;33(9):2306-2340
pubmed: 30899083
Cancer Genomics Proteomics. 2010 Jul-Aug;7(4):173-80
pubmed: 20656983
Oncotarget. 2018 Sep 18;9(73):33832-33843
pubmed: 30333913
Leuk Res. 2011 Aug;35(8):989-90
pubmed: 21492935
Nucleic Acids Res. 2013 Jan;41(Database issue):D955-61
pubmed: 23180760
Med Oncol. 2016 Nov;33(11):130
pubmed: 27757782
Leukemia. 2018 Feb;32(2):273-284
pubmed: 28701730
Bioinformatics. 2013 Jan 1;29(1):15-21
pubmed: 23104886
Cancer Lett. 2013 May 10;332(1):30-4
pubmed: 23340173
BMC Med Genomics. 2009 Jun 23;2:36
pubmed: 19549311
Blood. 2010 Apr 8;115(14):2835-44
pubmed: 20032505
Blood. 1997 May 15;89(10):3801-5
pubmed: 9160687
Biomark Res. 2018 Aug 23;6:27
pubmed: 30159143
Haematologica. 2018 Apr;103(4):e147-e150
pubmed: 29419436
Blood. 2004 Dec 1;104(12):3679-87
pubmed: 15226186
Nat Genet. 2002 Jan;30(1):41-7
pubmed: 11731795
Leukemia. 2003 Aug;17(8):1589-95
pubmed: 12886247
Front Pediatr. 2017 Feb 09;5:4
pubmed: 28232907

Auteurs

Bruno A Lopes (BA)

Acute Leukemia RioSearch Group, Division of Clinical Research and Technological Development, Instituto Nacional de Câncer José Alencar Gomes da Silva (INCA), Rio de Janeiro, Brazil.

Caroline Pires Poubel (CP)

Acute Leukemia RioSearch Group, Division of Clinical Research and Technological Development, Instituto Nacional de Câncer José Alencar Gomes da Silva (INCA), Rio de Janeiro, Brazil.
Bioinformatics and Computational Biology Laboratory, Instituto Nacional de Câncer José Alencar Gomes da Silva (INCA), Rio de Janeiro, Brazil.

Cristiane Esteves Teixeira (CE)

Bioinformatics and Computational Biology Laboratory, Instituto Nacional de Câncer José Alencar Gomes da Silva (INCA), Rio de Janeiro, Brazil.

Aurélie Caye-Eude (A)

Département de Génétique, UF de Génétique moléculaire, Assistance Publique des Hópitaux de Paris (AP-HP), Hópital Robert Debré, Paris, France.
INSERM UMR_S1131, Institut de Recherche Saint-Louis, Université de Paris-Cité, Paris, France.

Hélène Cavé (H)

Département de Génétique, UF de Génétique moléculaire, Assistance Publique des Hópitaux de Paris (AP-HP), Hópital Robert Debré, Paris, France.
INSERM UMR_S1131, Institut de Recherche Saint-Louis, Université de Paris-Cité, Paris, France.

Claus Meyer (C)

DCAL/Institute of Pharmaceutical Biology, Goethe-University Frankfurt, Frankfurt am Main, Germany.

Rolf Marschalek (R)

DCAL/Institute of Pharmaceutical Biology, Goethe-University Frankfurt, Frankfurt am Main, Germany.

Mariana Boroni (M)

Bioinformatics and Computational Biology Laboratory, Instituto Nacional de Câncer José Alencar Gomes da Silva (INCA), Rio de Janeiro, Brazil.

Mariana Emerenciano (M)

Acute Leukemia RioSearch Group, Division of Clinical Research and Technological Development, Instituto Nacional de Câncer José Alencar Gomes da Silva (INCA), Rio de Janeiro, Brazil.

Classifications MeSH